See historicals and forecasts on 21 key metrics for Nektar Therapeutics


Name Type
Basic And Diluted Net Loss Per Share Annual
Loss Before Provision For Income Taxes Annual
Loss From Operations Annual
Net Loss Annual
Non-operating Income Net Annual
Non-operating Income: Interest Expense Annual
Non-operating Income: Loss On Extinguishment Of Debt Annual
Non-operating Income: Non-cash Interest Expense On Liability Related To Sale Of Future Royalties Annual
Non-operating Income: Total Non-operating Expense Net Annual
Operating Costs And Expenses: Cost Of Goods Sold Annual
Operating Costs And Expenses: General And Administrative Annual
Operating Costs And Expenses: Impairment Of Equipment And Other Costs For Terminated Program Annual
Operating Costs And Expenses: Research And Development Annual
Operating Costs And Expenses: Total Operating Costs And Expenses Annual
Provision For Income Taxes Annual
Revenue: License Collaboration And Other Revenue Annual
Revenue: Non-cash Royalty Revenue Related To Sale Of Future Royalties Annual
Revenue: Product Sales Annual
Revenue: Royalty Revenue Annual
Revenue: Total Revenue Annual
Weighted Average Shares Outstanding Used In Computing Basic And Diluted Net Loss Per Share Annual